What is Rayaldee 30 mcg used for?
Rayaldee (calcifediol) 30 mcg tablets are used to treat secondary hyperparathyroidism in adults with chronic kidney disease (CKD) who have vitamin D deficiency. This is typically when patients are not adequately managed with lifestyle and/or other vitamin D approaches. [1]
What is “30 mcg” in Rayaldee?
“30 mcg” refers to the strength of each tablet of Rayaldee (calcifediol). Calcifediol is an activated form of vitamin D (25-hydroxyvitamin D) that the body can use to help raise vitamin D levels more directly than cholecalciferol in many cases. [1]
How does Rayaldee work?
Rayaldee increases circulating vitamin D, which helps suppress parathyroid hormone (PTH) over time in people with CKD-related secondary hyperparathyroidism. Lowering PTH is the main treatment goal in this indication. [1]
How is Rayaldee typically taken?
Rayaldee is an oral tablet. Dosing depends on the patient’s vitamin D status and the clinician’s plan for PTH control and monitoring. Exact dosing instructions can vary by prescription and local labeling; follow your prescriber’s directions. [1]
What side effects are people concerned about?
Common concerns with vitamin D analogs or vitamin D products include the risk of high calcium (hypercalcemia) and related symptoms, especially if dosing is too high or monitoring is not done. Kidney disease patients may need closer lab monitoring while on therapy. [1]
What should patients monitor while taking Rayaldee?
Clinicians typically monitor labs relevant to CKD and vitamin D therapy, including calcium and PTH, and may also check vitamin D levels. Monitoring is important because calcifediol can increase calcium levels in some patients. [1]
Is Rayaldee covered by patents or exclusivity—what’s the outlook for alternatives?
If you’re researching market exclusivity or upcoming generic competition for Rayaldee, DrugPatentWatch.com tracks patent and exclusivity details by brand and active ingredient. You can check current filings and timelines there: [2]
---
Sources
[1] https://www.drugs.com/rayaldee.html
[2] https://www.drugpatentwatch.com/